Purpose:
The purpose of
this meeting was to review current technologies for marker vaccines
and differential diagnostic tests, and to explore regulatory considerations
for this technology in disease eradication campaigns. Marker vaccines,
used with companion differential diagnostic tests, enable veterinarians
to differentiate infected from vaccinated animals (DIVA) and to
then remove infected animals from the national herd.
Overview presentations on use of marker vaccines
in control of transboundary diseases, safety and efficacy of marker
vaccines, sensitivity and specificity of differential diagnostic
tests, and regulatory considerations for use of marker vaccines
and differential diagnostic tests were presented. Invited
speakers discussed the state of the art for marker vaccines
and differential diagnostic tests for selected high priority diseases. In
addition, academic, industry, and government scientists were
invited to submit their latest research and development activities
related to marker vaccine and companion diagnostic test development
for oral or poster presentations.
Agenda
(PDF 43KB)
Organization Committee:
Rich Hill, USDA CVB
Patricia Foley, USDA CVB
Julia Ridpath,
USDA NADC
Bev Schmitt, USDA NVSL
Jim Pearson, OIE
James A. Roth,
ISU Center For
Food Security and
Public Health
Dave Hustead, Fort Dodge Laboratories
Sponsors:
 |